Archive for March, 2018
-
ACS Applied Materials and Interfaces Publication: Enzyme Prodrug Therapy Achieves Site-Specific, Personalized Physiological Responses to the Locally Produced Nitric Oxide
Our recent publication “Enzyme Prodrug Therapy Achieves Site-Specific, Personalized Physiological Responses to the Locally Produced Nitric Oxide” has been published in ACS Advance Materials and Interfaces. Nitric oxide (NO) is […]
![Our recent publication “Enzyme Prodrug Therapy Achieves Site-Specific, Personalized Physiological Responses to the Locally Produced Nitric Oxide” has been published in ACS Advance Materials and Interfaces. Nitric oxide (NO) is […]](http://www.zelikin-lab.com/wp-content/uploads/2018/04/localNO2_TOC_featured2-195x110.png "ACS Applied Materials and Interfaces Publication: Enzyme Prodrug Therapy Achieves Site-Specific, Personalized Physiological Responses to the Locally Produced Nitric Oxide")
![Our work on “Molecular, Macromolecular, and Supramolecular Glucuronide Prodrugs: Lead Identified for Anticancer Prodrug Monotherapy” has been recently published in Angewande Chemie. In this work, a tumor growth intervention by […]](http://www.zelikin-lab.com/wp-content/uploads/2020/03/Artboard-3_TOC_MacroGlucuronides_-36x36.png "New publication: Angewandte Chemie"){kind=small}